BioTransplant, MedImmune Inc. regulatory update

The companies received U.S. Patent No. 5,827,311 relating to BTRN’s BTI-322 antibody and MEDI’s MEDI-507 antibody, the humanized form of BTI-322. BTRN owns the patent, which covers the use of any anti...